{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:24:49Z","timestamp":1793679889648,"version":"4.5.1"},"reference-count":84,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010746","name":"Suomen Ihotautil\u00e4\u00e4k\u00e4riyhdistys","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finnish Medical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010129","name":"Maud Kuistilan Muistos\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011797","name":"Turun Yliopistollinen Keskussairaala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005609","name":"Turun Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnroothin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004012","name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022793","name":"Turun Yliopistos\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006081","name":"Lounais-Suomen Sy\u00f6p\u00e4yhdistys","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009420","name":"Tyks and Hospital District of Southwest Finland","doi-asserted-by":"publisher","award":["11027"],"award-info":[{"award-number":["11027"]}],"id":[{"id":"10.13039\/501100009420","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009420","name":"Tyks and Hospital District of Southwest Finland","doi-asserted-by":"publisher","award":["13336"],"award-info":[{"award-number":["13336"]}],"id":[{"id":"10.13039\/501100009420","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"HUS Helsinki University Hospital","doi-asserted-by":"publisher","award":["TYH2022315"],"award-info":[{"award-number":["TYH2022315"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007634","name":"Ida Montinin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["362240"],"award-info":[{"award-number":["362240"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["363211"],"award-info":[{"award-number":["363211"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jid.2025.04.007","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T03:54:43Z","timestamp":1745898883000},"page":"2854-2868.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Expression of C1q by Macrophages and Fibroblasts in Tumor Microenvironment Is Associated with Progression and Metastasis of Cutaneous Squamous Cell Carcinoma"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-681X","authenticated-orcid":false,"given":"Kristina","family":"Viiklepp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9255-6318","authenticated-orcid":false,"given":"Jaakko S.","family":"Knuutila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6743-6736","authenticated-orcid":false,"given":"Liisa","family":"Nissinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1709-8633","authenticated-orcid":false,"given":"Elina","family":"Siljam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-2842","authenticated-orcid":false,"given":"Pekka","family":"Rappu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9389-2911","authenticated-orcid":false,"given":"Ujjwal","family":"Suwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9652-7373","authenticated-orcid":false,"given":"Teijo","family":"Pellinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0686-6329","authenticated-orcid":false,"given":"Markku","family":"Kallajoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9142-501X","authenticated-orcid":false,"given":"Seppo","family":"Meri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2978-805X","authenticated-orcid":false,"given":"Jyrki","family":"Heino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-9368","authenticated-orcid":false,"given":"Veli-Matti","family":"K\u00e4h\u00e4ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2934-0645","authenticated-orcid":false,"given":"Pilvi","family":"Riihil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.04.007_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1172\/JCI90962","article-title":"The role of the complement system in cancer","volume":"127","author":"Afshar-Kharghan","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2025.04.007_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib3","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2025.04.007_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jaad.2017.07.031","article-title":"A new evidence-based risk stratification system for cutaneous squamous cell carcinoma into low, intermediate, and high risk groups with implications for management","volume":"78","author":"Baum","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fimmu.2019.01308","article-title":"Complement nomenclature-deconvoluted","volume":"10","author":"Bohlson","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib6","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1073\/pnas.1311968111","article-title":"C1q as a unique player in angiogenesis with therapeutic implication in wound healing","volume":"111","author":"Bossi","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2025.04.007_bib7","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/ijms20082009","article-title":"The role of the immune system in cutaneous squamous cell carcinoma","volume":"20","author":"Bottomley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2025.04.007_bib8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jso.23731","article-title":"The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system","volume":"110","author":"Brougham","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jid.2025.04.007_bib9","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.molimm.2007.12.025","article-title":"Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium","volume":"45","author":"Bulla","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10346","article-title":"C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation","volume":"7","author":"Bulla","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2025.04.007_bib11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41571-021-00546-5","article-title":"Clinical and therapeutic relevance of cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jid.2025.04.007_bib12","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202256467","article-title":"Reduced binding of apoE4 to complement factor H promotes amyloid-\u03b2 oligomerization and neuroinflammation","volume":"24","author":"Chernyaeva","year":"2023","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jid.2025.04.007_bib13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.celrep.2014.02.014","article-title":"Autocrine effects of tumor-derived complement","volume":"6","author":"Cho","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2025.04.007_bib85","article-title":"Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma","volume":"1","author":"Clingan","year":"2023","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib14","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.3390\/ijms21082956","article-title":"Cutaneous squamous cell carcinoma: from biology to therapy","volume":"21","author":"Corchado-Cobos","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2025.04.007_bib15","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.ccell.2021.04.016","article-title":"The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth","volume":"39","author":"Dong","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2025.04.007_bib16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ajpath.2011.05.012","article-title":"Serpin peptidase inhibitor clade A member 1 (SerpinA1) is a novel biomarker for progression of cutaneous squamous cell carcinoma","volume":"179","author":"Farshchian","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2025.04.007_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/exd.13109","article-title":"Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1\/2","volume":"26","author":"Farshchian","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib18","doi-asserted-by":"crossref","first-page":"45825","DOI":"10.18632\/oncotarget.17573","article-title":"Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma","volume":"8","author":"Farshchian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2025.04.007_bib19","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ajpath.2013.02.018","article-title":"Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling","volume":"182","author":"Frings","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2025.04.007_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1351656","article-title":"The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer","volume":"15","author":"Ghebrehiwet","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib21","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.03054","article-title":"Pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma: a single-arm phase II trial (KEYNOTE-629)","volume":"38","author":"Grob","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jid.2025.04.007_bib22","article-title":"Immune infiltration associated C1q acts as a novel prognostic biomarker of cutaneous melanoma","volume":"102","author":"Guo","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jid.2025.04.007_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010747","article-title":"Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival","volume":"5","author":"H\u00e4ggl\u00f6f","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2025.04.007_bib24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"Hajishengallis","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2025.04.007_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cell.2020.05.039","article-title":"Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma","volume":"23","author":"Ji","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jid.2025.04.007_bib27","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0190-9622(92)70074-P","article-title":"Squamous cell carcinoma of the skin (excluding lip and oral mucosa)","volume":"26","author":"Johnson","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/1471-2164-12-507","article-title":"Chipster: user-friendly analysis software for microarray and other high-throughput data","volume":"12","author":"Kallio","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jid.2025.04.007_bib29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-022-02677-z","article-title":"Refining colorectal cancer classification and clinical stratification through a single-cell atlas","volume":"23","author":"Khaliq","year":"2022","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2025.04.007_bib31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2133.2008.08466.x","article-title":"Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas","volume":"158","author":"Kivisaari","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib32","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3628","article-title":"Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: a cohort study","volume":"100","author":"Knuutila","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jid.2025.04.007_bib33","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/ijc.34957","article-title":"Cancer-associated fibroblast activation predicts progression, metastasis, and prognosis of cutaneous squamous cell carcinoma","volume":"155","author":"Knuutila","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12885-021-08912-3","article-title":"High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis","volume":"22","author":"Kou","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.21037\/atm.2016.06.26","article-title":"The dual role of complement in cancer and its implication in anti-tumor therapy","volume":"4","author":"Kourtzelis","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jid.2025.04.007_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fimmu.2015.00317","article-title":"Emerging and novel functions of complement protein C1q","volume":"6","author":"Kouser","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","article-title":"Analysis of the complement system in the clinical immunology laboratory","volume":"39","author":"Ling","year":"2019","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jid.2025.04.007_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imbio.2015.11.008","article-title":"The complement system in cancer: ambivalence between tumour destruction and promotion","volume":"222","author":"Mamidi","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.jid.2025.04.007_bib39","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.3389\/fimmu.2019.02366","article-title":"Prognostic implications of the complement protein C1q in gliomas","volume":"10","author":"Mangogna","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib40","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s40265-018-1012-5","article-title":"Cemiplimab: first global approval","volume":"78","author":"Markham","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jid.2025.04.007_bib41","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-23-0399","article-title":"The Yin Yang of complement and cancer","volume":"11","author":"Meri","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jid.2025.04.007_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104452","article-title":"An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers","volume":"88","author":"Mezheyeuski","year":"2023","journal-title":"EBiomedicine"},{"key":"10.1016\/j.jid.2025.04.007_bib43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1470-2045(19)30728-4","article-title":"Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial","volume":"21","author":"Migden","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2025.04.007_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.04.007_bib45","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1158\/1078-0432.CCR-18-1122","article-title":"Keratinocyte carcinomas: current concepts and future research priorities","volume":"25","author":"Nagarajan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2025.04.007_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64088-3","article-title":"C1s targeting antibodies inhibit the growth of cutaneous squamous carcinoma cells","volume":"14","author":"Nissinen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2025.04.007_bib47","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/ijms21041211","article-title":"Molecular approach to cutaneous squamous cell carcinoma: from pathways to therapy","volume":"21","author":"Palazzo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2025.04.007_bib48","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2353\/ajpath.2009.081030","article-title":"Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer","volume":"175","author":"Paulsson","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2025.04.007_bib49","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41592-021-01291-4","article-title":"MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity","volume":"18","author":"Peirsman","year":"2021","journal-title":"Nat Methods"},{"key":"10.1016\/j.jid.2025.04.007_bib50","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: A Hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2025.04.007_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/jdv.17400","article-title":"Treatment approaches of advanced cutaneous squamous cell carcinoma","volume":"36","author":"Peris","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.04.007_bib52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2017.08.059","article-title":"Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/cancers14020305","article-title":"Complement factor D is a novel biomarker and putative therapeutic target in cutaneous squamous cell carcinoma","volume":"14","author":"Rahmati Nezhad","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jid.2025.04.007_bib54","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1172\/JCI57415","article-title":"From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma","volume":"122","author":"Ratushny","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2025.04.007_bib55","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nri.2017.97","article-title":"Complement in cancer: untangling an intricate relationship","volume":"18","author":"Reis","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib56","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.trecan.2022.02.006","article-title":"C1q+ macrophages: passengers or drivers of cancer progression","volume":"8","author":"Revel","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib58","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ajpath.2017.01.006","article-title":"Complement component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma","volume":"187","author":"Riihil\u00e4","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2025.04.007_bib59","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/jid.2014.376","article-title":"Complement factor I promotes progression of cutaneous squamous cell carcinoma","volume":"135","author":"Riihil\u00e4","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib60","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.3390\/ijms20143550","article-title":"Complement system in cutaneous squamous cell carcinoma","volume":"20","author":"Riihil\u00e4","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2025.04.007_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/bjd.18095","article-title":"Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma","volume":"182","author":"Riihil\u00e4","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib62","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/jid.2013.346","article-title":"Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma","volume":"134","author":"Riihil\u00e4","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002757","article-title":"Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis","volume":"9","author":"Rischin","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib64","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ajh.25742","article-title":"Complement activation in sickle cell disease: dependence on cell density, hemolysis and modulation by hydroxyurea therapy","volume":"95","author":"Roumenina","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jid.2025.04.007_bib65","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/2326-6066.CIR-18-0891","article-title":"Tumor cells hijack macrophage-produced complement c1q to promote tumor growth","volume":"7","author":"Roumenina","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jid.2025.04.007_bib66","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-dependent roles of complement in cancer","volume":"19","author":"Roumenina","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib67","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0190-9622(92)70144-5","article-title":"Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection","volume":"26","author":"Rowe","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2018.03.006","article-title":"Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma","volume":"79","author":"Sasaki","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jid.2025.04.007_bib69","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1038\/s41467-023-41141-9","article-title":"Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma","volume":"14","author":"Sch\u00fctz","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2025.04.007_bib70","article-title":"Complement C1q induces the M2-polarization of tumor-associated macrophages in lung adenocarcinoma","volume":"11","author":"Song","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.jid.2025.04.007_bib71","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00011-014-0762-0","article-title":"Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins","volume":"63","author":"Spivia","year":"2014","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jid.2025.04.007_bib72","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: diagnostics and prevention-update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib73","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-update 2023","volume":"193","author":"Stratigos","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jid.2025.04.007_bib75","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jid.2025.04.007_bib76","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.21037\/jtd-24-304","article-title":"Increasing serum complement component 1q is associated with worse prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors: a single-center, retrospective study","volume":"16","author":"Tang","year":"2024","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jid.2025.04.007_bib77","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2017.05.025","article-title":"C1q: a fresh look upon an old molecule","volume":"89","author":"Thielens","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jid.2025.04.007_bib78","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jid.2021.09.010","article-title":"Activation of fibroblasts in skin cancer","volume":"142","author":"Van Hove","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib86","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1016\/j.jid.2025.03.016","article-title":"Current efficacy and safety and survival outcomes of cemiplimab in advanced cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"145","author":"Vasudevan","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2016.12.017","article-title":"Complement in autoimmune diseases","volume":"465","author":"Vignesh","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jid.2025.04.007_bib81","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jid.2021.10.008","article-title":"C1r Upregulates production of matrix metalloproteinase-13 and promotes invasion of cutaneous squamous cell carcinoma","volume":"142","author":"Viiklepp","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.04.007_bib82","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(23)01524-6","article-title":"Complement in human disease: approved and up-and-coming therapeutics","volume":"403","author":"West","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2025.04.007_bib83","doi-asserted-by":"crossref","first-page":"F516","DOI":"10.1152\/ajprenal.00604.2016","article-title":"Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis","volume":"312","author":"Xavier","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jid.2025.04.007_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239586","article-title":"Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"15","author":"Zeng","year":"2020","journal-title":"PLoS One"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25004464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T17:16:10Z","timestamp":1764263770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25004464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":84,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022202X25004464"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.007","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of C1q by Macrophages and Fibroblasts in Tumor Microenvironment Is Associated with Progression and Metastasis of Cutaneous Squamous Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}